Archive: 21/02/2020

Secondary analysis confirms safety of blood thinning agent

Treatment with the blood thinner apixaban was associated with a lower risk of bleeding, death and hospitalization compared with warfarin, regardless of history of prior stroke or blood clot, according to a secondary analysis ...

page 1 from 9